Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 530 participants.

Also called NCT04298723

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 530 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04298723
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany, Poland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04298723. Randomized; single masking; primary purpose prevention. Start 2020-06-16 (actual); primary completion 2029-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
Acronym
CLEARANCE
Condition
Intracranial Hemorrhages
Condition
Atrial Fibrillation (AF)
Intervention (Device)
Percutaneous closure of the LAA (Watchman / Watchman FLX)
Lead sponsor
Jena University Hospital (class: other)
Collaborator
KCRI (class: other)

Record details

Record id
cardio:ct-nct04298723
Content hash
20b366bf77b655e1fa230b1e1a7785291336efbbba6c230a38ba8facbc1cf0eb